LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | TGX221 | 0.12 | uM | LJP5 | 72 | hr | 868 | 2538 | 3486 | 0.7282 | 0.6380 |
MDA-MB-231 | Torin1 | 0.12 | uM | LJP6 | 72 | hr | 868 | 1718 | 3486 | 0.4928 | 0.3246 |
MDA-MB-231 | Torin2 | 0.12 | uM | LJP5 | 72 | hr | 868 | 1153 | 3486 | 0.3309 | 0.1091 |
MDA-MB-231 | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 868 | 1063 | 3486 | 0.3051 | 0.0747 |
MDA-MB-231 | Trametinib | 0.12 | uM | LJP5 | 72 | hr | 868 | 1278 | 3486 | 0.3668 | 0.1568 |
MDA-MB-231 | TWS119 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3524 | 3486 | 1.0108 | 1.0144 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 868 | 3233 | 3486 | 0.9274 | 0.9034 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP5 | 72 | hr | 868 | 3622 | 3486 | 1.0389 | 1.0518 |
MDA-MB-231 | Withaferin A | 0.12 | uM | LJP6 | 72 | hr | 868 | 3540 | 3486 | 1.0155 | 1.0206 |
MDA-MB-231 | WYE-125132 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2075 | 3486 | 0.5952 | 0.4609 |
MDA-MB-231 | WZ3105 | 0.12 | uM | LJP5 | 72 | hr | 868 | 716 | 3486 | 0.2056 | -0.0578 |
MDA-MB-231 | XMD11-50 | 0.12 | uM | LJP6 | 72 | hr | 868 | 2910 | 3486 | 0.8347 | 0.7799 |
MDA-MB-231 | Y39983 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3097 | 3486 | 0.8884 | 0.8514 |
MDA-MB-231 | YM 201636 | 0.12 | uM | LJP5 | 72 | hr | 868 | 3322 | 3486 | 0.9529 | 0.9373 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 868 | 3136 | 3486 | 0.8995 | 0.8662 |
MDA-MB-231 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 868 | 2774 | 3486 | 0.7957 | 0.7279 |
MDA-MB-231 | Sigma A6730 | 0.37 | uM | LJP5 | 72 | hr | 868 | 2971 | 3486 | 0.8523 | 0.8033 |
MDA-MB-231 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 868 | 611 | 3486 | 0.1753 | -0.0982 |
MDA-MB-231 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 868 | 965 | 3486 | 0.2768 | 0.0370 |
MDA-MB-231 | AZD 5438 | 0.37 | uM | LJP6 | 72 | hr | 868 | 1651 | 3486 | 0.4737 | 0.2991 |
MDA-MB-231 | AZD-6482 | 0.37 | uM | LJP5 | 72 | hr | 868 | 3027 | 3486 | 0.8682 | 0.8245 |
MDA-MB-231 | AZD7762 | 0.37 | uM | LJP6 | 72 | hr | 868 | 1351 | 3486 | 0.3876 | 0.1846 |
MDA-MB-231 | AZD8055 | 0.37 | uM | LJP6 | 72 | hr | 868 | 1365 | 3486 | 0.3915 | 0.1898 |
MDA-MB-231 | AZD8330 | 0.37 | uM | LJP5 | 72 | hr | 868 | 919 | 3486 | 0.2637 | 0.0196 |
MDA-MB-231 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 868 | 1244 | 3486 | 0.3570 | 0.1438 |